IMPEL PHARMACEUTICALS INC: cost_of_revenue
| Value | {"amount": 0, "concept": "us-gaap:CostOfRevenue", "currency": "USD"} |
|---|---|
| Period | 2020-07-01 – 2020-09-30 |
| Status | current |
| Entity | IMPEL PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:16:28.588953+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/06ea5f2b-f4d8-4f1f-bb1b-b2abae768e32
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-21-004479 · Open the official SEC filing →Retrieved: 2026-08-19T14:16:28.588953+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001445499/cost-of-revenue/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/06ea5f2b-f4d8-4f1f-bb1b-b2abae768e32
History
- no predecessors — first report